Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Grant or award Lebovits Chaim acquired 31,185 shares (grant or award)
  2. 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
  3. 4 Grant or award Director acquired 1,249 shares (grant or award)
  4. 4/A Open-market buy Director bought 5,700 shares at $3.50 ($19,950)
  5. 4/A Open-market buy COO and Chief Medical Officer bought 5,000 shares at $3.60 ($17,997)
  6. 4 Grant or award COO and Chief Medical Officer acquired 5,000 shares (grant or award)
  7. 4 Grant or award Director acquired 5,700 shares (grant or award)
  8. 4 Grant or award Director acquired 4,152 shares (grant or award)
  9. 4 Grant or award Director acquired 3,623 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award CFO and Treasurer acquired 25,000 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award Director acquired 8,666 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 12,000 shares (grant or award)
  17. 4 Grant or award Director acquired 2,000 shares (grant or award)
  18. 4 Open-market buy Director bought 2,500 shares at $4.26 ($10,650)
  19. 4 Open-market buy EVP & Chief Business Officer bought 2,000 shares at $3.98 ($7,960)
  20. 4 Grant or award Lebovits Chaim acquired 31,185 shares (grant or award)

Page 7 of 17 · 329 filings